Nuveen’s NantHealth, Inc NH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,401
Closed -$65K 3594
2022
Q1
$65K Sell
5,401
-3,296
-38% -$42K ﹤0.01% 3267
2021
Q4
$126K Sell
8,697
-67
-0.8% -$1.42K ﹤0.01% 3272
2021
Q3
$233K Sell
8,764
-212
-2% -$6.37K ﹤0.01% 3271
2021
Q2
$313K Sell
8,976
-246
-3% -$9.78K ﹤0.01% 3218
2021
Q1
$444K Buy
9,222
+1,125
+14% +$65.2K ﹤0.01% 3118
2020
Q4
$392K Buy
8,097
+129
+2% +$4.85K ﹤0.01% 3091
2020
Q3
$280K Buy
7,968
+1,622
+26% +$91.4K ﹤0.01% 3104
2020
Q2
$436K Buy
+6,346
New +$253K ﹤0.01% 2956

Other funds holding NH

Nuveen's NH Position: Q2 2022 in Review

Nuveen sold out of NantHealth, Inc (NH) in Q2 2022, closing a stake of 5,401 shares — an estimated $65K sold.

Nuveen first reported a position in NH in Q2 2020 and held it in 8 quarters. The position peaked at $444K in Q1 2021. 42 funds tracked by Wall St. Rank hold NH as of Q2 2022.

  • Nuveen reported no remaining NantHealth, Inc position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 5,401 NantHealth, Inc shares in Q2 2022, an estimated $65K.
  • Nuveen first reported a position in NantHealth, Inc in Q2 2020 and held it in 8 quarters.
  • Nuveen's NantHealth, Inc position peaked at $444K in Q1 2021.
  • 42 funds tracked by Wall St. Rank held NantHealth, Inc as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.